![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Leukemia |
Free Subscription
2 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Tumor lysis syndrome is associated with worse outcomes in adult patients with
acute lymphoblastic leukemia.
Acta Haematol. 2023 Nov 14. doi: 10.1159/000534453.
PubMed
Abstract available
A Rare Clinical Case of Secondary Central Nervous System Involvement without
Transformation in Hairy Cell Leukemia: Case Report and Literature Review.
Acta Haematol. 2023 Nov 10. doi: 10.1159/000535066.
PubMed
Abstract available
The FLT3(N701K) mutation causes clinical AML resistance to gilteritinib and
triggers TKI sensitivity switch to quizartinib.
Am J Hematol. 2023;98:E364-E368.
PubMed
Immune cell kinetics and antibody response in COVID-19 patients with low-count
monoclonal B-cell lymphocytosis.
Am J Hematol. 2023;98:1909-1922.
PubMed
Abstract available
Clonal myeloid disorders following CAR T-cell therapy.
Ann Hematol. 2023;102:3643-3645.
PubMed
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by
inhibiting STUB1-induced NFAT5 ubiquitination.
Ann Hematol. 2023 Nov 10. doi: 10.1007/s00277-023-05522.
PubMed
Abstract available
Efficacy of venetoclax combined with decitabine conditioning regimen for
allogeneic hematopoietic stem cell transplantation in high-risk and elderly
patients with myeloid neoplasms.
Ann Hematol. 2023;102:3603-3611.
PubMed
Abstract available
Epstein-Barr virus reactivation correlates with worse outcomes for patients
exposed to hepatitis B virus after haploidentical hematopoietic stem cell
transplantation.
Ann Hematol. 2023;102:3593-3601.
PubMed
Abstract available
Changing treatment changing prognosis of mutations.
Blood. 2023;142:1583-1585.
PubMed
Melanoma and CLL co-occurrence and survival: role of KC history.
BMC Cancer. 2023;23:1084.
PubMed
Abstract available
Phase I non-randomized clinical trial of allogeneic natural killer cells infusion
in acute myeloid leukemia patients.
BMC Cancer. 2023;23:1090.
PubMed
Abstract available
Peripheral blood stem cell transplantation from haploidentical related donor
could achieve satisfactory clinical outcomes for intermediate- or high-risk adult
acute myeloid leukemia patients.
Bone Marrow Transplant. 2023 Nov 15. doi: 10.1038/s41409-023-02117.
PubMed
Abstract available
Frequency and outcomes of obinutuzumab-induced thrombocytopenia.
Br J Haematol. 2023;203:668-672.
PubMed
Abstract available
Rethinking the definition of 'less intensive' for venetoclax-combining regimens
in acute myeloid leukaemia patients.
Br J Haematol. 2023;203:504-506.
PubMed
Abstract available
Invasive fungal infection following venetoclax and posaconazole
co-administration.
Br J Haematol. 2023;203:593-598.
PubMed
Abstract available
Blinatumomab differentially modulates peripheral blood and bone marrow immune
cell repertoire: A Campus ALL study.
Br J Haematol. 2023;203:637-650.
PubMed
Abstract available
Disseminated invasive aspergillosis in a patient treated with ibrutinib for
chronic lymphocytic leukaemia.
Br J Haematol. 2023;203:499-500.
PubMed
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS
and AML patients.
Br J Haematol. 2023;203:625-636.
PubMed
Abstract available
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic
leukaemia.
Br J Haematol. 2023;203:581-592.
PubMed
Abstract available
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early
mortality and survival in acute myeloid leukaemia patients treated with
hypomethylating agents and venetoclax.
Br J Haematol. 2023;203:e98-e101.
PubMed
Counts, incidence rates, and trends of pediatric cancer in the United States,
2003-2019.
J Natl Cancer Inst. 2023;115:1337-1354.
PubMed
Abstract available
Thank you for your interest in scientific medicine.